This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Mar;7(3):204-206.

doi: 10.1016/S2213-2600(19)30040-2.

The way forward for tuberculosis vaccines

Richard G White¹, Willem A Hanekom², Johan Vekemans³, Rebecca C Harris⁴

Affiliations

Affiliations

¹ TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: richard.white@lshtm.ac.uk.
² Tuberculosis, Global Health Department, Bill & Melinda Gates Foundation, Seattle, WA, USA.
³ Initiative for Vaccine Research, WHO, Geneva, Switzerland.
⁴ TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

PMID: 30823973
DOI: 10.1016/S2213-2600(19)30040-2

The way forward for tuberculosis vaccines

Richard G White et al. Lancet Respir Med. 2019 Mar.

. 2019 Mar;7(3):204-206.

doi: 10.1016/S2213-2600(19)30040-2.

Authors

Richard G White¹, Willem A Hanekom², Johan Vekemans³, Rebecca C Harris⁴

Affiliations

¹ TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: richard.white@lshtm.ac.uk.
² Tuberculosis, Global Health Department, Bill & Melinda Gates Foundation, Seattle, WA, USA.
³ Initiative for Vaccine Research, WHO, Geneva, Switzerland.
⁴ TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

PMID: 30823973
DOI: 10.1016/S2213-2600(19)30040-2

Erratum in

Correction to Lancet Respir Med 2019; 7: 204-06.
[No authors listed] [No authors listed] Lancet Respir Med. 2019 Apr;7(4):e15. doi: 10.1016/S2213-2600(19)30092-X. Lancet Respir Med. 2019. PMID: 30926053 No abstract available.

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information